Skip to main
GMTX

Gemini Therapeutics (GMTX) Market Capitalization Overview

Market Cap: $2.99B as of Jan 8, 2026

$2.99B
$488.87M (14.04%)past month
As of Jan 8, 2026, Gemini Therapeutics (GMTX) has a market capitalization of $2.99B. Over the past 30 days, its market cap has decreased by -13.74%, while in the last 12 months, it has decreased by -0.15%.

Market capitalization represents the total value of Gemini Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Gemini Therapeutics (GMTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Gemini Therapeutics (GMTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Gemini Therapeutics (GMTX) Market Cap History

DateMarket CapChange
Dec 1, 2025$3.47B+9.32%
Nov 3, 2025$3.17B+35.84%
Oct 1, 2025$2.34B+9.19%
Sep 2, 2025$2.14B+4.52%
Aug 1, 2025$2.05B+15.33%
Jul 1, 2025$1.78B+7.12%
Jun 2, 2025$1.66B-3.92%
May 1, 2025$1.73B+5.56%
Apr 1, 2025$1.63B-13.22%
Mar 3, 2025$1.88B-0.40%
Feb 3, 2025$1.89B+1.47%
Jan 2, 2025$1.86B-2.76%

Gemini Therapeutics (GMTX) End of Year Market Cap History

DateMarket CapChange
2026$2.99B-0.15%
2025$2.99B+58.89%
2024$1.89B+35.31%
2023$1.40B+1,519.03%
2022$86.13M-31.51%
2021$125.74M

FAQs About Gemini Therapeutics (GMTX) Market Cap

As of Jan 8, 2026, the market capitalization of Gemini Therapeutics (GMTX) is $2.99B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Gemini Therapeutics’s market capitalization has decreased by -14.04%, changing from $3.49B to $2.99B as of Jan 8, 2026.

In the last 3 months, Gemini Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Gemini Therapeutics’s market capitalization increased from $1.89B in January to $2.99B in December, reflecting a 58.89% change.

In the past five years, Gemini Therapeutics (GMTX) has had a compound annual growth rate (CAGR) of 88.57% in market capitalization. This means its market cap has grown at an average rate of 88.57% per year.

Gemini Therapeutics (GMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.